Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
55 participants
INTERVENTIONAL
2017-09-15
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Volunteer-delivered Behavioral Activation
Volunteer-delivered Behavioral Activation
Behavioral Activation as delivered by trained volunteers
MSW-delivered Behavioral Activation
MSW-delivered Behavioral Activation
Behavioral Activation as delivered by trained MSWs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Volunteer-delivered Behavioral Activation
Behavioral Activation as delivered by trained volunteers
MSW-delivered Behavioral Activation
Behavioral Activation as delivered by trained MSWs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Age ≥ 60 years.
2. Attends one of 4 participating Seattle senior centers.
3. PHQ-9 score of ≥10 via routine screening.
Research assessment (stage 2):
1. Mini Mental State Exam (MMSE) ≥ 24.
2. Capacity to provide written consent for both research assessment and the BA intervention.
Exclusion Criteria
2. Presence of psychiatric diagnoses other than unipolar, non-psychotic major depression or anxiety disorder by SCID-V.
3. Severe or life-threatening medical illness (e.g., end stage organ failure).
4. Inability to speak English.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patrick Raue
Professor, School of Medicine: Psychiatry: Population Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick J Raue, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Greenwood Senior Center
Seattle, Washington, United States
Wallingford Senior Center
Seattle, Washington, United States
Southeast Senior Center
Seattle, Washington, United States
Central Area Senior Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00002543
Identifier Type: -
Identifier Source: org_study_id